Caplin Point Laboratories Ltd Share Price NSE India S.E.
Stocks
INE475E01018
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
||
| - INR | - |
|
| Market Cap | 20TCr 207.83Cr 182.28Cr 168.83Cr 155.34Cr 293.82Cr 299.54Cr 2.01TCr 789.2Cr 9.77TCr 780.41Cr 763.34Cr 34TCr | P/E 2026 |
17.9x | P/E 2027 * | 27.9x |
|---|---|---|---|---|---|
| Enterprise Value | 20TCr 207.83Cr 182.28Cr 168.83Cr 155.34Cr 293.82Cr 299.54Cr 2.01TCr 789.2Cr 9.77TCr 780.41Cr 763.34Cr 34TCr | EV / Sales 2026 |
5.23x | EV / Sales 2027 * | 7.99x |
| Free-Float |
26.39% | Yield 2026 * |
-
| Yield 2027 * | 0.15% |
Last Transcript: Caplin Point Laboratories Ltd
| Manager | Title | Age | Since |
|---|---|---|---|
Sridhar Ganesan
CEO | Chief Executive Officer | 71 | 28/03/2015 |
D. Muralidharan
DFI | Director of Finance/CFO | - | 19/02/2016 |
Anto V.
ADM | Chief Administrative Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 27/01/2010 | |
| Director/Board Member | - | 05/11/2025 | |
Sridhar Ganesan
BRD | Director/Board Member | 71 | 28/03/2015 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.73% | +0.45% | +14.92% | +78.63% | 4.87TCr | |
| +1.05% | -3.82% | +67.30% | +117.28% | 3.64TCr | |
| -0.88% | -3.10% | -3.93% | +39.78% | 1.22TCr | |
| -1.69% | -1.45% | +15.49% | +91.28% | 1.2TCr | |
| +1.53% | +1.53% | +33.50% | +127.47% | 904.09Cr | |
| -1.57% | -3.25% | +16.67% | +36.55% | 709.46Cr | |
| +0.87% | -1.44% | +47.88% | -4.47% | 706.36Cr | |
| +0.81% | +1.34% | +5.51% | +236.82% | 675.48Cr | |
| -5.52% | -11.93% | -22.06% | +7.41% | 610.48Cr | |
| Average | -0.67% | -0.67% | +19.47% | +81.19% | 1.62TCr | |
| Weighted average by Cap. | -0.33% | +0.01% | +27.35% | +87.40% |
| 2026 | 2027 * | |
|---|---|---|
| Net sales | 2.13TCr 22Cr 19Cr 18Cr 17Cr 31Cr 32Cr 215.26Cr 84Cr 1.04TCr 83Cr 82Cr 3.61TCr | 2.49TCr 26Cr 23Cr 21Cr 19Cr 37Cr 37Cr 251.68Cr 99Cr 1.22TCr 98Cr 95Cr 4.22TCr |
| Net income | 616.2Cr 6.44Cr 5.65Cr 5.23Cr 4.81Cr 9.1Cr 9.28Cr 62Cr 24Cr 302.6Cr 24Cr 24Cr 1.05TCr | 712.75Cr 7.45Cr 6.53Cr 6.05Cr 5.57Cr 11Cr 11Cr 72Cr 28Cr 350.02Cr 28Cr 27Cr 1.21TCr |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
